» Articles » PMID: 12884917

Regulators of G1 Cyclin-dependent Kinases and Cancers

Overview
Specialty Oncology
Date 2003 Jul 30
PMID 12884917
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

The mammalian cell cycle can be divided into four phases: G1 (gap phase 1), S (DNA synthesis), G2 (gap phase 2), and M (mitosis). Progression through each phase of the cell cycle is delicately controled by the activity of different cyclin-dependent kinases (CDKs) and their regulatory subunits known as cyclins. CDK2, CDK4, CDK6 and their associated cyclins control the G1 to S phase transition. The association of CDK4 or CDK6 with D-type cyclins is critical for G1 phase progression, whereas the CDK2-cyclin E complex is important for initiation of the S phase. Cancer can originate from dysregulation of these regulators. A variety of intrinsic and extrinsic signals were recently identified to regulate these G1 or G1/S CDKs and cyclins. Here we discuss the regulators of these protein kinases at different mechanistic level with a hope that these insights can be applied to develop therapeutic strategies for cancer treatment.

Citing Articles

Novel pharmacologic inhibition of lysine-specific demethylase 1 as a potential therapeutic for glioblastoma.

Shinjo K, Umehara T, Niwa H, Sato S, Katsushima K, Sato S Cancer Gene Ther. 2024; 31(12):1884-1894.

PMID: 39501082 PMC: 11645267. DOI: 10.1038/s41417-024-00847-8.


Facilitates the Tumorigenesis of Lung Adenocarcinoma by Promoting Cell Cycle Progression through the Upregulation of CDK4.

Feng B, Wang X, Qiu D, Sun H, Deng J, Tan Y Int J Mol Sci. 2024; 25(9).

PMID: 38732173 PMC: 11084921. DOI: 10.3390/ijms25094953.


MYCT-1 Gene Expression in Patients with Gastric Cancer: an Ex Vivo Study.

Dong X, Xue S, Chen C, Jiang Z, Wu X, Wang W Appl Biochem Biotechnol. 2023; 196(8):5114-5126.

PMID: 38112991 DOI: 10.1007/s12010-023-04754-w.


Dedifferentiated Low-Grade Osteosarcoma, Outcome with or Without Chemotherapy: A Systematic Review.

Pacheco M, Guzman R, Bonilla P Orthop Res Rev. 2023; 15:79-89.

PMID: 37143718 PMC: 10153403. DOI: 10.2147/ORR.S404146.


Identification of genes and pathways leading to metastasis and poor prognosis in melanoma.

Zhang X, Wang W, Wang Y, Jiang G Aging (Albany NY). 2021; 13(18):22474-22489.

PMID: 34582363 PMC: 8507267. DOI: 10.18632/aging.203554.